compounded semaglutide crackdown news november 2025 FDA ESCALATES: 30 telehealth companies hit with warning letters for false claims on GLP-1 drugs. The agency accuses firms of misleading consumers by implying unapproved compounded versions match FDA-approved medications compounded semaglutide crackdown news october

This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only

According to OBRA, the use of antidiabetic medications should include monitoring (e.g., periodic blood glucose) for effectiveness based on desired goals for that individual and to identify complications of treatment such as hypoglycemia or impaired renal function

Work with your provider to reduce your dose over several weeks rather than stopping suddenly

Outlandish claims of effortless weight loss and reversal of diabetes with no side effects should be met with extreme skepticism, especially when not evaluated and approved by reputable regulatory agencies like the FDA, or backed by peer-reviewed clinical research

If you encounter mild or occasional discomfort, it may subside as your body adapts to the medication

How Does Tirzepatide Powder Compare to Semaglutide Powder in Mechanism